Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Medicinal Foods Highlights Customer Feedback on Original Dentite Tooth Armor
EIN Presswire
Customer feedback brings renewed attention to the nano-hydroxyapatite brushing booster for enamel remineralization and sensitivity support.
New Haven Man Sentenced for Medicaid Theft
Connecticut State Division of Criminal Justice
(Rocky Hill, CT) – Chief State’s Attorney Patrick J. Griffin today announced that a New Haven man has been sentenced in New Haven Superior Court for defrauding the Connecticut Medicaid Program by billing for personal care services he did not...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire, Inc.
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today...
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
GlobeNewswire, Inc.
LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12,...
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
GlobeNewswire, Inc.
Company awaiting comments from FDA by the end of August 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
GlobeNewswire, Inc.
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and Q&A session on Monday,...
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire, Inc.
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations...
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
GlobeNewswire, Inc.
SAN FRANCISCO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has been filed after its surprising revelations concerning a Phase...
NMRTC Bremerton honors Navy Medical Service Corps legacy on 79th anniversary
DVIDS - Georgia
BREMERTON, Wash. – Navy Medicine Readiness and Training Command (NMRTC) Bremerton marks the 79th birthday of the U.S. Navy Medical Service Corps (MSC) during a celebration on the command quarterdeck, Aug. 4, 2026. Established on Aug. 4, 1947, when...
ARS PHARMACEUTICALS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ARS Pharmaceuticals and Encourages Investors to Contact the Firm
GlobeNewswire, Inc.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In ARS (SPRY) To Contact Him Directly To Discuss Their Options If you purchased or acquired ARS securities between March 9, 2026, and June 24,...
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire, Inc.
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ARS Pharmaceuticals Inc. (NASDAQ: SPRY) and certain of...
Labrador Letter: Idaho Urges Congress to Give States the Tools to Stop Medicaid Fraud
Idaho Office of Attorney General
Home Newsroom Labrador Letter: Idaho Urges Congress to Give States the Tools to Stop Medicaid Fraud Dear Friends, In May, I told you about a trip to the White House, where I sat down with Vice President JD Vance, FTC Chairman Andrew Ferguson, and...
Gynecology Medical Lasers Market Study Explores Industry Growth Toward $3.08 Billion
EIN Presswire
The Business Research Company's Gynecology Medical Lasers Market Study Explores Industry Growth Toward $3.08 Billion LONDON, GREATER LONDON, UNITED KINGDOM, August 7, 2026 /EINPresswire.com/ -- "The gynecology medical lasers market is rapidly...
SPRY Deadline Alert: The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. (SPRY) Investors of Securities Class Action Deadline on October 5, 2026
GlobeNewswire, Inc.
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). Shareholders who purchased shares of SPRY during the class period listed are encouraged to...
REGN Deadline Alert: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of Securities Class Action Deadline on September 14, 2026
GlobeNewswire, Inc.
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged...
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire, Inc.
LOS ANGELES, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ: REGN)...
AMLC delivers critical medical device training to the tactical edge
DVIDS - Georgia
FORT DETRICK, Md.– U.S. Army Medical Logistics Command is bridging the gap between fielding new medical technology and sustaining it by delivering critical, hands-on training directly to military maintainers across the force.
Navy Medicine Research & Development Concludes MHSRS 2026 with Awards and Recognitions.
DVIDS - Georgia
KISSIMMEE, Fla.– Navy Medicine Research & Development’s (NMR&D) attendance at the 2026 Military Health System Research Symposium (MHSRS), Aug. 3-6 at the Gaylord Palms Resort and Convention Center, concluded this past Thursday.
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
GlobeNewswire, Inc.
VALENCIA, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it will be participating at the Canaccord Genuity...
Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026
GlobeNewswire, Inc.
ASHBURN, Va., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to...
Sign up for:
Today in Medicine
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.